SIMPLEX TRADING, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330909. A total of 4 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$476
-57.7%
41,500
-6.7%
0.00%
-100.0%
Q2 2023$1,126
-28.9%
44,500
-9.6%
0.00%0.0%
Q1 2023$1,584
+88.8%
49,200
+8.1%
0.00%0.0%
Q4 2022$839
-100.0%
45,500
-46.7%
0.00%
-66.7%
Q3 2022$2,305,000
+451.4%
85,400
+181.8%
0.00%
Q2 2022$418,000
-67.5%
30,300
-54.1%
0.00%
-100.0%
Q1 2022$1,287,000
+101.4%
66,000
+68.4%
0.00%0.0%
Q4 2021$639,000
-47.6%
39,200
-1.8%
0.00%0.0%
Q3 2021$1,219,000
+3.1%
39,9000.0%0.00%0.0%
Q2 2021$1,182,000
+244.6%
39,900
+32339.0%
0.00%0.0%
Q1 2021$343,000
-46.4%
123
-45.6%
0.00%0.0%
Q4 2020$640,000
+105.8%
226
+82.3%
0.00%
Q3 2020$311,000
-66.4%
124
-67.3%
0.00%
-100.0%
Q2 2020$925,000
+66.1%
379
+0.5%
0.00%0.0%
Q1 2020$557,000
+278.9%
377
+314.3%
0.00%
Q4 2019$147,000
+72.9%
91
+37.9%
0.00%
Q3 2019$85,000
+193.1%
66
+187.0%
0.00%
Q2 2019$29,000
-82.6%
23
-78.3%
0.00%
Q1 2019$167,000
+153.0%
106
+221.2%
0.00%
Q4 2018$66,000
-78.0%
33
-72.7%
0.00%
-100.0%
Q3 2018$300,000
-46.9%
121
-41.3%
0.00%
-50.0%
Q2 2018$565,000
+6962.5%
206
-6.4%
0.00%
Q1 2018$8,000
-96.1%
220
-66.9%
0.00%
-100.0%
Q4 2017$204,000
+2450.0%
665
+4650.0%
0.01%
Q3 2017$8,000
-57.9%
14
-58.8%
0.00%
-100.0%
Q2 2017$19,00034
+750.0%
0.00%
Q1 2017$04
+33.3%
0.00%
Q4 2016$03
-57.1%
0.00%
Q3 2016$07
-56.2%
0.00%
Q2 2016$0
-100.0%
16
-95.5%
0.00%
-100.0%
Q4 2015$29,000
+383.3%
352
+3100.0%
0.00%
Q3 2015$6,000
-76.0%
11
-57.7%
0.00%
-100.0%
Q2 2015$25,000260.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 687,700$12,694,9420.01%
GROUP ONE TRADING, L.P. 47,500$876,8500.00%
SIMPLEX TRADING, LLC 45,500$8390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REVANCE THERAPEUTICS INC shareholders